Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache

M. J. Belgrade, L. J. Ling, M. B. Schleevogt, M. G. Ettinger, E. Ruiz

Research output: Contribution to journalArticle

48 Scopus citations

Abstract

We treated 64 emergency room patients with a primary vascular headache with dihydroergotamine (DHE), meperidine, or butorphanol. Post-treatment pain scores were lowest in the DHE group (p < 0.01). Eight of 21 patients receiving DHE had greater than 90% reduction in pain compared with three of 19 patients receiving butorphanol and none of 22 receiving meperidine.

Original languageEnglish (US)
Pages (from-to)590-592
Number of pages3
JournalNeurology
Volume39
Issue number4
StatePublished - Apr 1989

Fingerprint Dive into the research topics of 'Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache'. Together they form a unique fingerprint.

  • Cite this

    Belgrade, M. J., Ling, L. J., Schleevogt, M. B., Ettinger, M. G., & Ruiz, E. (1989). Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache. Neurology, 39(4), 590-592.